Efficacy [qlco]
Gemfibrosil [lipd, phsu]
Dyslipidaemia [dsyn]
Subject [grup]
Suspected [idcn]
Heart disease [dsyn]
Ancillary Study [resa]
Heart study [diap]
Frame [nusq]
Screening [hlca]
Heart study [diap]
coronary [bpoc]
Primary Prevention [topp]
Trial [resa]
Gemfibrosil [lipd, phsu]
Dyslipidaemia [dsyn]
Detected [fndg]
Exhibit [inpr]
symptoms [ftcn]
signs [ftcn]
coronary heart disease [dsyn]
Subject [grup]
Excluded [idcn]
Primary [qlco]
Study [mnob]
secure [bodm]
Successful [qlco]
Conduct [inbe]
Ancillary [idcn]
Protocol [inpr]
treatment [ftcn]
Eleven [qnco]
Subject [grup]
randomized [resa]
Receive [qlco]
Gemfibrozil 600 MG [clnd]
Twice daily [tmco]
Subject [grup]
Receive [qlco]
MATCHING [resa]
placebo [topp]
DOUBLE BLIND [resa]
End Point [qlco]
Fatal [qlco]
Fatal [qlco]
Myocardial Infarction [dsyn]
Cardiac Death [patf]
placebo [topp]
Gemfibrosil [lipd, phsu]
Group [idcn]
Same [qlco]
True [qlco]
Mortality [qnco]
Missing [idcn]
Prognostic Factor [clna]
True [qlco]
coronary heart disease [dsyn]
Extent [spco]
Coronary artery [bpoc]
obstructions [patf]
Degree [qlco]
Ventricular Dysfunction, Left [patf]
distribution [idcn]
Group [idcn]
Reliability [qnco]
thesis [inpr]
treatment [ftcn]
Dyslipidaemia [dsyn]
Manifest [ftcn]
coronary heart disease [dsyn]
Successful [qlco]
